Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
BOTICA COMERCIAL FARMACÊUTICA LTDA. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct art unit, indicating a specific point of contact within the patent office for the company's current filings. The prosecution is handled by a distinct examiner, meaning all active legal efforts are concentrated with one individual. This arrangement reflects a focused interaction with the patent office during this period.
JANOSKO, CHASITY PAIGE is identified as the busiest examiner, responsible for the 1 pending office action currently active. Because there is only 1 pending office action in the entire portfolio, this examiner controls the entirety of the company's immediate prosecution outcomes. The involvement of the distinct art unit and the distinct examiner simplifies the administrative burden but focuses risk on a single result. There are no other pending cases to provide a baseline for comparison within the company's own current portfolio.
For a practitioner, this concentration means that a deep understanding of the specific preferences of JANOSKO, CHASITY PAIGE is essential. The success of the company's Biotechnology & Pharmaceuticals strategy is currently dependent on the resolution of the active matter. Without multiple cases to manage, the applicant can dedicate full attention to the technical and procedural requirements of the assigned art unit. This approach is necessary when the prosecution landscape is limited to a single point of contact.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257931 | METHOD FOR OBTAINING A LIGNIN COMPOSITION ASSOCIATED WITH ZNO AND TIO2 FOR A COSMETIC PRODUCT WITH COLORING FOR BLACK SKIN, TO BOOST BLUE LIGHT PROTECTION, AND TO PROTECT THE SKIN AGAINST EXTERNAL OXIDIZING AGENTS, AND RESPECTIVE OBTAINED PRODUCT | JANOSKO, CHASITY PAIGE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257931 | METHOD FOR OBTAINING A LIGNIN COMPOSITION ASSOCIATED WITH ZNO AND TIO2 FOR A COSMETIC PRODUCT WITH COLORING FOR BLACK SKIN, TO BOOST BLUE LIGHT PROTECTION, AND TO PROTECT THE SKIN AGAINST EXTERNAL OXIDIZING AGENTS, AND RESPECTIVE OBTAINED PRODUCT | JANOSKO, CHASITY PAIGE | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18257931 | METHOD FOR OBTAINING A LIGNIN COMPOSITION ASSOCIATED WITH ZNO AND TIO2 FOR A COSMETIC PRODUCT WITH COLORING FOR BLACK SKIN, TO BOOST BLUE LIGHT PROTECTION, AND TO PROTECT THE SKIN AGAINST EXTERNAL OXIDIZING AGENTS, AND RESPECTIVE OBTAINED PRODUCT | JANOSKO, CHASITY PAIGE | 1613 | §103§112 | Final Rejection | — | Pending | Jun 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBOTICA COMERCIAL FARMACÊUTICA LTDA. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Chasity Paige Janosko has the most, with 1 of BOTICA COMERCIAL FARMACÊUTICA LTDA.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
